Abstract
Sonodynamic Photodynamic Therapy (SPDT) is a novel cancer treatment approach using a photosensitive agent (Sonnelux-1) with reported ultrasound-activated properties. The sensitiser is administered prior to a cycle of light and low-intensity ultrasound exposure. Ultrasound has the advantage of significantly greater tissue penetrance compared to light, which potentially allows non-invasive activation of the sensitiser within deep-sited tumours. Sonnelux-1 has previously demonstrated significant tumour cell inhibition following ultrasound administration in animal studies, and several case reviews have been published reporting clinical benefits in metastatic cancer patients. This current case series presents outcome measures of five patients with a variety of cancer diagnoses following SPDT, providing further evidence of beneficial treatment outcomes.
Keywords: Sonodynamic therapy, photodynamic therapy, immunoediting, cancer, ultrasound, photosensitiser, malignant pathologies, tetra pyrrole, porphyrin ring, energy, molecular oxygen, cell necrosis, cytotoxicity, absorption, tissues, physiotherapy, safety, tumour growth, death, wavelengths, histology, Oncology, lymph nodes, T cell, lymphocyte division, radiotherapy, chemotherapy, photooxidative cytotoxic, neutrophilia, OZONE, AUTOHAEMOTHERAPY, TUMOUR HYPOXIA, infusion, oestrogen, progesterone, receptor, chest infections, X Ray, biopsy
Current Drug Therapy
Title: Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series
Volume: 6 Issue: 1
Author(s): Julian Norman Kenyon and Richard James Fuller
Affiliation:
Keywords: Sonodynamic therapy, photodynamic therapy, immunoediting, cancer, ultrasound, photosensitiser, malignant pathologies, tetra pyrrole, porphyrin ring, energy, molecular oxygen, cell necrosis, cytotoxicity, absorption, tissues, physiotherapy, safety, tumour growth, death, wavelengths, histology, Oncology, lymph nodes, T cell, lymphocyte division, radiotherapy, chemotherapy, photooxidative cytotoxic, neutrophilia, OZONE, AUTOHAEMOTHERAPY, TUMOUR HYPOXIA, infusion, oestrogen, progesterone, receptor, chest infections, X Ray, biopsy
Abstract: Sonodynamic Photodynamic Therapy (SPDT) is a novel cancer treatment approach using a photosensitive agent (Sonnelux-1) with reported ultrasound-activated properties. The sensitiser is administered prior to a cycle of light and low-intensity ultrasound exposure. Ultrasound has the advantage of significantly greater tissue penetrance compared to light, which potentially allows non-invasive activation of the sensitiser within deep-sited tumours. Sonnelux-1 has previously demonstrated significant tumour cell inhibition following ultrasound administration in animal studies, and several case reviews have been published reporting clinical benefits in metastatic cancer patients. This current case series presents outcome measures of five patients with a variety of cancer diagnoses following SPDT, providing further evidence of beneficial treatment outcomes.
Export Options
About this article
Cite this article as:
Norman Kenyon Julian and James Fuller Richard, Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series, Current Drug Therapy 2011; 6 (1) . https://dx.doi.org/10.2174/157488511794079059
DOI https://dx.doi.org/10.2174/157488511794079059 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Black Tea Polyphenols-Mediated In Vivo Cellular Responses During Carcinogenesis
Mini-Reviews in Medicinal Chemistry From 2D to 3D - a New Dimension for Modelling the Effect of Natural Products on Human Tissue
Current Pharmaceutical Design Role of Polyamines in Breast Cancer Growth, Development and Progression
Current Cancer Therapy Reviews Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Current Medicinal Chemistry Protocatechuic Acid and Human Disease Prevention: Biological Activities and Molecular Mechanisms
Current Medicinal Chemistry Renal Heat Shock Proteins Over-Expression Due to Anabolic Androgenic Steroids Abuse
Mini-Reviews in Medicinal Chemistry Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design ER Stress and Autophagy
Current Molecular Medicine Multidimensional Ophthalmic Nanosystems for Molecular Detection and Therapy of Eye Disorders
Current Pharmaceutical Design Vitiligo: Pathogenetic Hypotheses and Targets for Current Therapies
Current Drug Metabolism Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Current Clinical Pharmacology Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models
Current Medicinal Chemistry Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples
Recent Patents on Biomarkers Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Cellular Targets and Mechanisms in the Cytotoxic Action of Non-biodegradable Engineered Nanoparticles
Current Drug Metabolism The Promise of Plant Polyphenols as the Golden Standard Skin Anti-Inflammatory Agents
Current Drug Metabolism Wnt Signaling in Liver Cancer
Current Drug Targets Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo
Current Cancer Drug Targets The Influence of Cox-2 and Bioactive Lipids on Hematological Cancers
Current Angiogenesis (Discontinued) Epigenetic Regulation of Epithelial to Mesenchymal Transition
Current Cancer Drug Targets